Consistency of medical abortion efficacy from 5 through 14 weeks' gestation

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 129, Issue 1, 2006, Pages 36-40

  Garbin, Olivier ^a   Vayssiere, Christophe ^a   Bettahar Lebugle, Karima ^a   Nisand, Israel ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Medical abortion; Mifepristone; Misoprostol

Indexed keywords

BUPRENORPHINE; DOXYCYCLINE; KETOPROFEN; METOCLOPRAMIDE; MIFEPRISTONE; PARACETAMOL;

ADOLESCENT; ADULT; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG USE; EPIDURAL ANESTHESIA; FEMALE; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UTERUS; VACUUM ASPIRATION;

EID: 33750410043     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.11.001     Document Type: Article

References (25)

1. Mac Kinley C., Thong K.J., and Baird D.T. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Human Reprod 8 (1993) 1502-1505
2. World Health Organisation Task Force on Post-Ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br J Obstet Gynaecol 107 (2000) 524-530
3. World Health Organisation Task Force on Post-Ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. Br Med J 307 (1993) 532-537
4. El-Refaey H., and Templeton A. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure. Br J Obstet Gynaecol 101 (1994) 792-796
5. Peyron R., Aubeny E., Targosz V., et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 328 21 (1993) 1509-1513
6. Spitz I.M., Bardin C.W., Benton L., and Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338 18 (1998) 1241-1247
7. Ashok P.W., Flett G.M., and Templeton A. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol. Lancet 352 (1998) 542-543
8. Ashok P.W., Kidd A., Flett G.M., Fitzmaurice A., Graham W., and Templeton A. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Hum Reprod 17 1 (2002) 92-98
9. Ashok P.W., Penney G.C., Flett G.M., and Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 13 (1998) 2962-2965
10. El Refaey H., Rajasekar D., Abdalla M., Calder L., and Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332 15 (1995) 983-987
11. Gouk E.V., Lincoln K., Khair A., Haslock J., Knight J., and Cruickshank D.J. Medical termination of pregnancy at 63 to 83 days gestation. Br J Obstet Gynaecol 106 (1999) 535-539
12. Schaff E.A., Eisinger S.H., Stadalius L.S., Franks P., Gore B.Z., and Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 59 (1999) 1-6
13. Schaff E.A., Fielding S.L., Eisinger S.H., Stadalius L.S., and Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 h for abortion up to 63 days. Contraception 61 (2000) 41-46
14. Schaff E.A., Fielding S.L., Westhoff C., et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. JAMA 284 15 (2000) 1948-1953
15. Ashok P.W., and Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 106 (1999) 706-710
16. Webster D., Penney G.C., and Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol 103 (1996) 706-709
17. El Refaey H., and Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 10 (1995) 475-478
18. Ho P.C., Ngai S.W., Liu K.L., Wong G.C., and Lee S.W. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol 90 5 (1997) 735-738
19. Grimes D.A., Schulz K.F., Cates W., and Tyler C.W. Local versus general anesthesia: which is saver for performing suction curettage abortions?. Am J Obstet Gynecol 135 (1979) 1030-1035
20. Schulz K.F., Grimes D.A., and Cates W. Measures to prevent cervical injury during suction curettage abortion. Lancet 1 (1983) 1182-1185
21. Cameron S., Glasier A., Logan J., Benton L., and Baird D. Impact of the introduction of a new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh. Br J Obstet Gynaecol 103 (1996) 1222-1229
22. Thonneau P., Poirel H., Fougeyrollas B., et al. A comparative analysis of fall in haemoglobin following abortions conducted by mifepristone (600 mg) and vacuum aspiration. Hum Reprod 10 (1995) 1512-1515
23. Henshaw R.C., Naji S.A., Russel I.T., and Templeton A. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration. Efficacy and early medical sequelae. Hum Reprod 9 (1994) 2167-2172
24. Howie F.L., Henshaw R.C., Naji S.A., Russel I.T., and Templeton A. Medical abortion or vacuum aspiration? Two years follow up of a patient preference trial. Br J Obstet Gynaecol 104 (1997) 829-833
25. Slade P., Heke S., Fletcher J., and Stewart P. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care. Br J Obstet Gynaecol 105 (1998) 1288-1295